Algeria Pharmaceuticals ISI Model

Algeria's pharmaceutical market, remains by far the largest existing market in the Middle East and North African (MENA) region, and this for various reasons , first, the country's universal health system, second, the country's rapid population growth, and third, the country's political willingness to encourage market development allowing for a greater production share. However, eradicating supply shortages, and aligning domestic pharmaceuticals supply with demand has been and will remain a constant and fragile monitoring exercise for the country's health policymakers.

Autorentext

Dr Djamel Eddine Laouisset is Professor at Alhosn University . He was Advisor to the UAE Minister of Economy , was University Vice Chancellor for Graduate Studies & Research , was Director of Studies & Research at the National Institute for Global Strategic Studies (Algeria). He is the Middle East Representative for The Africa Academy of Management